healthcare

The Ripple Effect: Investing in Life Sciences | Episode 2: How life sciences investment drives economic growth | GZERO Blue Circle x Novartis

The Ripple Effect: Investing in Life Sciences

How life sciences investment drives economic growth

In this episode of The Ripple Effect: Investing in Life Sciences, host Dan Riskin speaks with Patrick Horber, President of Novartis International, and David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare at Lazard. Together, they break down the outsized economic impact of life science innovation, from trillions in US bioscience output to China’s meteoric rise as a global R&D hub.

How AI will revolutionize medicine, and cancer research

GZERO World with Ian Bremmer Podcast

How AI will revolutionize medicine with Siddhartha Mukherjee

Ian Bremmer sits down with physician and author Siddhartha Mukherjee to explore how AI is revolutionizing cancer treatment and drug discovery.

Next Giant Leap: Could the future of industry lie among the stars? | GZERO Blue Circle x MDA Space | Image of the moon

Next Giant Leap

Could the future of industry lie among the stars?

Creating artificial human retinas in zero gravity. Mining rare minerals on the moon. There seems to be no limit to what could be possible if we continue to take our more important industries to space. Join Mike Massimino and Mike Greenley on this episode of Next Giant Leap as they explore the industrialization of space. Dr. Joan Saary sheds light on the potential of designing medical treatments in microgravity and treating astronauts in orbit, and Dr. Gordon Osinski explains the exciting future of resource extraction on other planetary objects.

Using AI to diagnose patients with a smartphone but no healthcare access

Using AI to diagnose patients with a smartphone but no healthcare access

Artificial intelligence is often seen as a futuristic tool—but for some global health challenges, it’s already the only solution. Dr. Juan Lavista Ferres, Microsoft's Chief Data Scientist, Corporate Vice President, and Lab Director for the AI for Good Lab, points to a powerful example: diagnosing a leading cause of childhood blindness in newborns.

GZERO World with Ian Bremmer Podcast

How Trump is remaking US public health, with NY Times reporter Apoorva Mandavilli

Listen: President Trump has already made sweeping changes to US public health policy—from RFK Jr.’s nomination to lead the health department to withdrawing the US from the World Health Organization. On the GZERO World Podcast, New York Times science and global health reporter Apoorva Mandavilli joins Ian Bremmer for an in-depth look at health policy in the Trump administration, and what it could mean, not just for the US, but for the rest of the world.

Trump's health agenda—from RFK Jr. to leaving WHO

GZERO World with Ian Bremmer

Trump's health agenda—from RFK Jr. to leaving WHO

From RFK Jr.’s nomination to lead the health department to an executive order withdrawing the US from the World Health Organization, President Trump has already made sweeping changes to public health policy, and this may be just the beginning. On GZERO World, New York Times Science and Global Health Reporter Apoorva Mandavilli joins Ian Bremmer for an in-depth look at health and medicine in the second Trump administration—and what it could mean, not just for the US, but for the rest of the world.